Starpax Biopharma

Starpax Biopharma Inc. has developed a novel Precision 3D Guidance Therapy of MagnetodronesTM in tumors. MagnetodronesTM are unique medication-bearing bacteria, developed by StarpaxTM, that are sensitive to magnetic fields. They deliver the medication into the mass of the tumour, without allowing the medication to circulate in the bloodstream. At the same time, the MagnetodronesTM saturate hypoxic areas where cancerous cells are difficult to reach with other treatments. Magnetodrones are injected directly into the tumour and are guided by the PolarTrak device, in which the patient is positioned. The PolarTrakTM prevents the MagnetodronesTM from leaving the tumour and guides them in...

Drug delivery,oncology,cancer treatment,medical device,cancer stem cell treatment,biopharmaceuticals,and biotechnology

Starpax biopharma operates in the Biotechnology research industry.

Starpax biopharma's revenue is 11m - 100m

Starpax biopharma has 11 - 50 employees.